Inspire Corporate Bond ETFIBD

InspireBonds & CashCorporate#557 of 785 by YTD

$23.31

+0.3% last session

−0.3% YTD

Data as of 11/4/20264:00 PM ET · End-of-day

Dividend-adjusted total return · S&P 500 uses VOO · Dec 31, 2025 – Nov 4, 2026IBDS&P 500 · VOOBonds & Cash average

Returns	1D	1M	3M	YTD	1Y	3Y	5Y	MAX
Total return	+0.3%	+1.3%	−0.3%	−0.3%	+1.0%	+18.9%	+6.9%	+20.0%
Peer average	+0.4%	+1.3%	−0.1%	+0.5%	+1.4%	+20.5%	+5.7%	—
S&P 500 · VOO	+1.6%	−1.6%	0.0%	+13.4%	+13.5%	+91.7%	+81.2%	—

Key Statistics

Open all fund facts →

AUM: $480M
Expense ratio: 0.41%
Distribution yield: 4.4%
NAV: $23.28
Volume: 50K
Avg. volume 30D: 129K
High today: $23.51
Low today: $23.24
Previous close: $23.25
52-week high: $24.78
52-week low: $22.50
Our risk indicator: 2/5

IBD in One Breath

IBD Among Corporate ETFs

YTD

#1BCLOiShares+4.8%$113M

#2CLOCAAM+4.7%$60.8M

#3RAAAReckoner+4.6%$45.0M

#4PCMMBondBloxx+4.5%$268M

#5PSQAPalmer Square+4.4%$250M

#6NCLONuveen+4.4%$243M

#7ACLOTCW+4.3%$595M

#8RCLOReckoner+4.1%$44.6M

#78IBDInspire−0.3%$480M

End-of-day Nov 5, 2026 · 139 Corporate ETFs by YTD

$10,000 in IBD

$10,000 in IBD became

$10,693

In the S&P 500 (VOO)

$18,115

Total return, dividends in · Oct 27, 2021 – Nov 4, 2026 · S&P 500 uses VOO

IBD’s Top Holdings

Today

AZO 3 3/4 06/0AZO 3 3/4 06/01/272.3%VLO 4.35 06/2.3%APH 4.35 06/2.3%ARE 4.9 12/12.3%CPT 4.9 01/12.2%SUI 2.3 11/02.2%GEV 4 7/8 022.2%MDLZ 4 3/4 02.2%MSCI 5 1/4 02.2%ADP 4.45 09/2.2%JBL 3.6 01/12.2%EVRG 2.9 09/2.2%CAT 2.6 09/12.2%ATO 2 5/8 092.2%CSL 2 3/4 032.1%FANG 3 1/8 02.1%MKC 2 1/2 042.1%BXP 3 1/4 012.1%AMCR 2.69 052.1%EXR 2.55 06/2.0%SWK 3 05/15/2.0%FTNT 2.2 03/2.0%

Inspire IBD · 12 holdings · tile size = share of the fund · as of Nov 4, 2026

What IBD Holds

Today

All holdings100.0%

AZO 3 3/4 2.3 · VLO 4.35 0 2.3 · APH 4.35 0 2.3 · ARE 4.9 12 2.3 · CPT 4.9 01 2.2 · SUI 2.3 11 2.2 · GEV 4 7/8 2.2

Inspire IBD · share of the fund · as of Nov 4, 2026

AZO’s Share of IBD

Today

2.3%

$23 of every $1,000 in IBD is AZO

AZO held by IBD

$11.1M

Inspire IBD · each square = $10 of $1,000 · as of Nov 4, 2026

IBD’s Share of Corporate ETFs

Today

0.1%

of the $396B in 169 Corporate ETFs

IBD$480M0.1%

VCIT$66.6B16.8%

VCSH$43.9B11.1%

166 others$285B72.0%

Corporate ETF AUM · Nov 5, 2026

IBD Fee per $100 vs Peers

Today

$0.41a year
per $100

$41 a year on $10,000

VCIT$0.03

VCSH$0.03

IGSB$0.04

LQD$0.14

JAAA$0.20

IBD$0.41

Expense ratio · Corporate peers · Nov 5, 2026

Inside IBD

12 holdings · as of Nov 4, 2026

IBD

Inspire Corporate Bond ETF

Today

All holdings100.0%AZO 3 3/4 2.3%VLO 4.35 02.3%APH 4.35 02.3%ARE 4.9 122.3%CPT 4.9 012.2%SUI 2.3 112.2%GEV 4 7/8 2.2%Mdlz 4 3/42.2%Msci 5 1/42.2%ADP 4.45 02.2%JBL 3.6 012.2%Evrg 2.9 02.2%86 more holdings69.0% of the fund

All holdings100.0%94 more holdings86.4% of the fund

#	Ticker	Company	Weight ▼
1	—	AZO 3 3/4 06/01/27	2.31%
2	—	VLO 4.35 06/01/28	2.30%
3	—	APH 4.35 06/01/29	2.28%
4	—	ARE 4.9 12/15/30	2.26%
5	—	CPT 4.9 01/15/34	2.22%
6	—	SUI 2.3 11/01/28	2.20%
7	—	GEV 4 7/8 02/04/36	2.19%
8	—	Mdlz 4 3/4 08/28/34	2.19%
9	—	Msci 5 1/4 09/01/35	2.19%
10	—	ADP 4.45 09/09/34	2.18%

Inspire IBD · current holdings by weight · as of Nov 4, 2026 · each tile is one holding · top 20 = 43.6%

How It Compares

IBD

Inspire Corporate Bond ETF’s Peers

YTD


VCIT	VanguardRead Desk	0.03%	−0.9%	+0.1%	$66.6B
VCSH	VanguardRead Desk	0.03%	+1.2%	+2.1%	$43.9B
LQD	iSharesRead Desk	0.14%	−1.4%	−0.9%	$32.8B
JAAA	Janus HendersonRead Desk	0.20%	+3.8%	+4.8%	$32.3B
IGSB	iSharesRead Desk	0.04%	+1.3%	+2.2%	$23.6B
IBD	InspireThis fundRead Desk	0.41%	−0.3%	+1.0%	$480M

Corporate peers · YTD and past-year returns · as of Nov 5, 2026 · sorted by AUM

Head to Head

Put IBD head to head with VCIT →

VCIT vs IBD

YTD

VCITVanguard · CorporateIBDInspire · Corporate

Year to date

−0.9%

−0.3%

IBD wins+0.6 pts

Past year

+0.1%

+1.0%

IBD wins+0.9 pts

Fee

0.03%

0.41%

VCIT winslower fee

Yield

5.0%

4.4%

VCIT wins+0.6 pts

AUM

$66.6B

$480M

VCIT138.9× more

2–2level

Vanguard VCIT and Inspire IBD · year-to-date · as of Nov 5, 2026 · AUM not scored

IBD vs VOO

YTD

IBD · Inspire Corporate Bond

−0.3%

VOO · S&P 500

+13.4%

Gap

13.6 pts

Inspire IBD and Vanguard VOO · YTD total return · as of Nov 5, 2026

IBD vs Its Peer Average

YTD

IBDAvsBPeer average

1D+0.3%+0.4%

1M+1.3%+1.3%

3M−0.3%−0.1%

YTD−0.3%+0.5%

1Y+1.0%+1.4%

3Y+18.9%+20.5%

5Y+6.9%+5.7%

1–6Peer average wins

168 Corporate peers · each row scaled to its leader

The Details

IBD

Risk

2/5our risk indicator

CalmerBumpier

Volatility · 1Y4.30%

Deepest drop · 1Y−2.8%

Lowest point · 5Y−12.0%

52-week range

$23.31

$22.50−5.9% from the high$24.78

Inspire IBD · past-year price moves · as of Nov 5, 2026

IBD

Fund Facts

Today

2017launched Jul 10

Tracks[…]

Exchange · CUSIPAMEX · 66538H633

StructureETF

Leverage1x

Cost on $10,000$41 a year

Go deeper

Prospectus & documents Trading & liquidity Fees & costs Distributions

Inspire IBD · fund facts · as of Nov 5, 2026

IBD

Payouts by Year

$0.10per share, Oct 2026

Distribution yield4.4%

PaidEvery month

Latest ex-date · paidOct 28 · Nov 2, 2026

12 payouts added up$1.03 a share

Inspire IBD · distributions by ex-date · 2021–2026

All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

Trading & Liquidity

Net asset value$23.28

Premium / discount[…]

Median spread · 30D[…]

Volume today50K

Average volume · 30D129K

Shares outstanding[…]

Options[…]

Fees & Costs

Net expense ratio0.41%

Gross expense ratio[…]

Management fee[…]

Cost on $10,000 a year$41.00

Our risk indicator2/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-date	Paid	Per share
Oct 28, 2026	Nov 2, 2026	$0.10
Sep 25, 2026	Oct 1, 2026	$0.0820
Aug 26, 2026	Aug 31, 2026	$0.0904
Jul 24, 2026	Jul 29, 2026	$0.0762
Jun 26, 2026	Jul 1, 2026	$0.0959
May 22, 2026	May 27, 2026	$0.0776
Apr 24, 2026	Apr 29, 2026	$0.0788
Mar 27, 2026	Apr 1, 2026	$0.0932
Feb 24, 2026	Mar 2, 2026	$0.0779
Jan 27, 2026	Feb 2, 2026	$0.0592
Dec 17, 2025	Dec 24, 2025	$0.12
Nov 21, 2025	Nov 26, 2025	$0.0729

Issuer contentFrom InspireHear the strategy from the people behind IBD.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →